Real estate developer Park Properties has announced the start of construction works for SunLake Snagov Signature Collection, a high-end residential complex located on the shore of Lake Snagov, near Bucharest.
Romanian developer Park Properties has partnered with entrepreneur George Peltecu to develop Sunlake Snagov Signature Collection, a development of 22 lakeside villas with a private marina. The project will be built on a 15,000 sqm plot on Lake Snagov shores, with construction starting this spring.
Real estate developer Park Properties has purchased a 15,000 sqm land plot on the shores of Lake Snagov, near Bucharest, for a luxury villa residential development.
In addition to SunLake Snagov, the developer is also working on SunLake Residence, SunLake Homes and SunLake Pipera projects.
The developer is currently developing 700 residential units in Bucharest, Pipera, Corbeanca/Balotești and other locations in the country.
Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Uber Technologies announced new products and features at its annual Go-Get product event, including hotel bookings and travel tools that are planned to roll out globally in the coming months.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.